NOA Co-Chairs
Professor John Zalcberg OAM
Head, Cancer Research Program in the School of Public Health and Preventive Medicine within the Faculty of Medicine, Nursing and Health Sciences at Monash University.
Richard Vines
Chair & Chief Executive, Rare Cancers Australia;
Deputy Chair, Australian Genomics Cancer Medicine Program;
Co-chair, Consumer Advisory Board, Australian Genomic Health Alliance (AGHA);
Director, Patient Voice Initiative.
Pillar Heads
NOA believes that change comes through collaboration and it works across a number of groups that support and underpin it’s goals - NOA calls those groups ‘pillars’ and they’re categorised by the shared experience of the members of the group. Pillar Heads report to the Steering Committee.
Patient Group Pillar
Peter Orchard
Ceo, CanTeen
Clinician Pillar
Prof. Clare Scott
Walter + Eliza Hall Institute of Medical Research
Prof. David Thomas
NHMRC Principal Research Fellow, Director, Kinghorn Cancer Centre and Head of the Centre Division, Garvan Institute of Medical Research
Industry Pillar
Liz Chatwin
Country President, AstraZeneca
Steering Committee
- Liz Chatwin
Country Manager, AstraZeneca - Bruce Goodwin
Managing Director, Janssen - Jane Kerr
General Manager, Thoracic Cancers & Rare Lung Disease, Lung Foundation - Barrie Littlefield
Head of Engagement, Cure Brain Cancer Foundation - Jonathan Pincus
Patient Advocate - Peter Orchard
CEO, CanTeen - Nicola Richards
Executive Director, Market Access & Public Affairs, MSD - Professor Clare Scott
Walter + Eliza Hall Institute of Medical Research - Professor David Thomas
NHMRC Principle Research Fellow, Director, Kinghorn Cancer Centre and Head of the Cancer Division, Garvan Institute NSW Garvan Institute of Medical Research